Press release
Cholestatic Pruritus Pipeline Assessment (2023 Updates) | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, Treatment Outlook, and Key Companies | Escient Pharma, Cara Therapeutics, Gla
"Cholestatic Pruritus Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Cholestatic Pruritus Therapeutics Market.
The report provides a detailed description of the drug, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).
The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Cholestatic Pruritus Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing therapies in the Cholestatic Pruritus Market.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cholestatic Pruritus treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Cholestatic Pruritus market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, featured press releases from company/university websites, industry-specific third-party sources, etc.
Learn More about the Clinical and Commercial Development Activities in the Cholestatic Pruritus Therapeutics Domain:
https://www.delveinsight.com/report-store/cholestatic-pruritus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
Route of Administration
Cholestatic Pruritus pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal
Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule
Mechanism of Action of the Emerging Pipeline Therapies
• C-reactive protein inhibitors
• Opioid kappa receptor agonists
• Sodium-bile acid cotransporter inhibitors
• MRGPRX4 Activator
Request for Sample PDF to Understand More About the Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/report-store/cholestatic-pruritus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Cholestatic Pruritus Therapeutics Analysis
Several major pharma and biotech companies are developing therapies for Cholestatic Pruritus. Currently, GlaxoSmithKline is leading the therapeutics market with its Cholestatic Pruritus drug candidates in the most advanced stage of clinical development.
The Leading Companies in the Cholestatic Pruritus Therapeutics Market Include:
• Escient Pharmaceuticals
• Cara Therapeutics
• GlaxoSmithKline
• CymaBay Therapeutics
• Mirum Pharmaceuticals
And Many Others
Cholestatic Pruritus Emerging and Marketed Therapies Covered in the Report Include:
• Volixibat: Mirum Pharmaceuticals
• Linerixibat: GlaxoSmithKline
• EP 547: Escient Pharmaceuticals
• Seladelpar: CymaBay Therapeutics
• LUM001: Mirum Pharmaceuticals
• Korsuva: Cara Therapeutics
And Many More
Get an in-depth Assessment of the Emerging Therapies and Key Companies:
https://www.delveinsight.com/sample-request/cholestatic-pruritus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Cholestatic Pruritus Current Treatment Patterns
4. Cholestatic Pruritus - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Cholestatic Pruritus Late-Stage Products (Phase-III)
7. Cholestatic Pruritus Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Cholestatic Pruritus Discontinued Products
13. Cholestatic Pruritus Product Profiles
14. Cholestatic Pruritus Key Companies
15. Cholestatic Pruritus Key Products
16. Dormant and Discontinued Products
17. Cholestatic Pruritus Unmet Needs
18. Cholestatic Pruritus Future Perspectives
19. Cholestatic Pruritus Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/cholestatic-pruritus-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Other Trending Healthcare Reports by DelveInsight
Bronchial Neoplasm Market
https://www.delveinsight.com/report-store/bronchial-neoplasm-market
Gastro Intestinal Bleeding Market
https://www.delveinsight.com/report-store/gastro-intestinal-bleeding-market
Orthostatic Hypotension Market
https://www.delveinsight.com/report-store/orthostatic-hypotension-market
Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market
Schistosomiasis Market
https://www.delveinsight.com/report-store/schistosomiasis-market
Vulvodynia Market
https://www.delveinsight.com/report-store/vulvodynia-market
Indolent Lymphoma Market
https://www.delveinsight.com/report-store/indolent-lymphoma-market
Liver Angiosarcoma Market
https://www.delveinsight.com/report-store/liver-angiosarcoma-market
Osteochondrodysplasia Market
https://www.delveinsight.com/report-store/osteochondrodysplasia-market
Tuberous Sclerosis Complex Market
https://www.delveinsight.com/report-store/tuberous-sclerosis-complex-market
Ocular Melanoma Market
https://www.delveinsight.com/report-store/ocular-melanoma-market
Mucopolysaccharidosis I Market
https://www.delveinsight.com/report-store/mucopolysaccharidosis-i-market
Bone Resorption Market
https://www.delveinsight.com/report-store/bone-resorption-market
Hot Flashes Market
https://www.delveinsight.com/report-store/hot-flashes-market
Cryptococcosis Market
https://www.delveinsight.com/report-store/cryptococcosis-market
Gene Therapy for Ocular Rare Disease Market
https://www.delveinsight.com/report-store/gene-therapy-for-ocular-rare-disease-market
Hypersomnia Market
https://www.delveinsight.com/report-store/hypersomnia-market
CART-related Neurotoxicity (NT) Market
https://www.delveinsight.com/report-store/cart-related-neurotoxicity-nt-market
Drug Hypersensitivity Market
https://www.delveinsight.com/report-store/drug-hypersensitivity-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cholestatic Pruritus Pipeline Assessment (2023 Updates) | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, Treatment Outlook, and Key Companies | Escient Pharma, Cara Therapeutics, Gla here
News-ID: 3061355 • Views: …
More Releases from DelveInsight Business Research LLP
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myelofibrosis therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Myelofibrosis…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hemophilia therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights! Download DelveInsight's comprehensive Hemophilia…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer pipeline landscape. It covers the Non Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Non Muscle Invasive Bladder Cancer therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the Hearing Loss pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hearing Loss therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead with the latest insights!…
More Releases for Cholestatic
Cholestatic Pruritus Market is expected to reach USD 3.4 billion by 2034
Cholestatic pruritus is one of the most debilitating complications of chronic liver diseases, particularly cholestasis, primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC). The persistent itching severely impairs patients' quality of life and remains a complex therapeutic challenge for healthcare providers worldwide. As awareness of liver disorders increases and pharmaceutical pipelines expand, the global cholestatic pruritus market is entering a transformative growth phase.
Download Full PDF Sample Copy of Market…
Global Cholestatic Pruritus Market Analysis 2025-2030: Growth Drivers, Challenge …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Cholestatic Pruritus Market Size Expected to Be by 2034?
The market for cholestatic pruritus has experienced significant growth in the past few years. Projected to expand from $19.20 billion in 2024 to $20.28 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 5.6%. Factors contributing to…
Cholestatic Pruritus Market Size in 7MM is expected to grow at a decent CAGR by …
DelveInsight's "Cholestatic Pruritus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as the Cholestatic Pruritus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover which therapies are expected to grab the Cholestatic Pruritus Market Share @ Cholestatic Pruritus Market Outlook- https://www.delveinsight.com/sample-request/cholestatic-pruritus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Cholestatic Pruritus Market Report
• In March…
Cholestatic Pruritus Treatment Market Size in 7MM is expected to grow at a decen …
DelveInsight's "Cholestatic Pruritus Market Insights, Epidemiology, and Market Forecast-2032" Report delivers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as the Cholestatic Pruritus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover which therapies are expected to grab the Cholestatic Pruritus Market Share @ Cholestatic Pruritus Market Outlook- https://www.delveinsight.com/sample-request/cholestatic-pruritus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Cholestatic Pruritus Market Report
• In April…
Cholestatic Pruritus Market Expected to Experience Major Growth by 2032, Accordi …
DelveInsight's "Cholestatic Pruritus Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as the Cholestatic Pruritus market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Cholestatic Pruritus market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Cholestatic Pruritus Market Forecast
https://www.delveinsight.com/sample-request/cholestatic-pruritus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Cholestatic Pruritus Market to Observe Impressive Growth During the Forecast Per …
The Cholestatic Pruritus Market Forecast report offers an in-depth understanding of the Cholestatic Pruritus, historical and forecasted epidemiology as well as the Cholestatic Pruritus market trends in the 7MM.
Cholestatic Pruritus Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Escient Pharma, GlaxoSmithKline, Mirum Pharma, Albireo, Regeneron Pharma
DelveInsight's "Cholestatic Pruritus Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Cholestatic Pruritus, historical and…
